Competition for biotech and pharma employment picked up year over year and remains strong, according to BioSpace data. A survey late last year showed that 64% of employed/contract and 96% of ...
Saudi pharma’s rise as a global CDMO destination: Investment, infrastructure, and competitive edge
Industry reports the Saudi pharmaceutical CDMO market is expected to increase from USD $1.62 billion in 2024 to USD $2.24 ...
On Thursday, Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) reported fourth-quarter adjusted EPS of 92 cents, up from 88 cents a year ago, but missing the consensus of 94 cents. Amphastar is a ...
In the second part of his Pharma Commerce video interview, Franco Stevanato, CEO of Stevanato Group, describes how from FDA ...
Pharmaceutical Technology on MSN
Walking the pharma supply chain tightrope requires more than precision
Staying ahead of pharma supply challenges rests on anticipatory pillars and does not require reinventing the wheel, says ...
These corporate actions come as Vincerx Pharma, headquartered in San Mateo, California, continues to navigate the competitive pharmaceutical industry, with a focus on developing treatments in its ...
Stressing the need for the restoration of Weighted R&D Deduction (up to 200%), he noted that it would significantly boost ...
Biomarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best biotech stocks to buy according to Wall Street analysts. On November 18, BioMarin Pharmaceutical (NASDAQ:BMRN) presented at the Jefferies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback